ArticleClinical pharmacology and therapeutics2021

Do Inhibitory Metabolites Impact DDI Risk Assessment? Analysis of in vitro and in vivo Data from NDA Reviews Between 2013 and 2018.

Claire Steinbronn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.